Pancreatic Cancer Research

ResearcherBaptist Hospital of MiamiActive in the last 2 years

Kathryn Elizabeth Mittauer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6213-611X; OpenAlex author ID A5060760243. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 7

  1. Patterns of Failure After Definitive Ablative 5-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2026.03.048↗
  2. Ablative Five-Fraction CT Versus MR-Guided Stereotactic Body Radiation Therapy for Pancreatic Cancer: In Silico Evaluation of Interfraction Anatomic Changes as… Co-author DOI 10.3390/cancers17132061↗
  3. Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hyp… Co-author DOI 10.3390/cancers17152596↗
  4. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Co-author DOI 10.1016/j.radonc.2023.110064↗
  5. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
  6. Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer. Co-author DOI 10.1016/j.radonc.2023.109869↗
  7. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report. Last author DOI 10.1016/j.meddos.2021.04.006↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael David Chuong · 7 shared papers, 2021–2026 · strength 1.21
  2. Adeel Kaiser · 3 shared papers, 2025–2026 · strength 0.65
  3. John Michael Bryant · 2 shared papers, 2021–2023 · strength 0.30
  4. Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
  5. John Ng · 2 shared papers, 2023–2024 · strength 0.27
  6. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
  7. Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
  8. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
  9. Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
  10. Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
  11. Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
  12. Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
  13. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
  14. Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
  15. Parag Jitendra Parikh · 2 shared papers, 2023–2024 · strength 0.27
  16. Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
  17. Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
  18. Carla Hajj · 1 shared paper, 2025 · strength 0.20
  19. Marsha Reyngold · 1 shared paper, 2025 · strength 0.20
  20. Abraham Jing-Ching Wu · 1 shared paper, 2025 · strength 0.20
  21. Eileen Mary O'Reilly · 1 shared paper, 2025 · strength 0.20
  22. Christopher H. Crane · 1 shared paper, 2025 · strength 0.20
  23. Delia G. Doty · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.